Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05509530
What this trial is testing

Safety and Efficacy of Anti-BCMA/GPRC5D CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma(rr/MM)

Who this might be right for
Multiple Myeloma
Xuzhou Medical University 30
Large-scale testing (Phase 3)Study completedNCT02609828
What this trial is testing

Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy

Who this might be right for
Bone MetastasisCancer Pain
Pfizer 156
Not applicableUnknownNCT03089411
What this trial is testing

Collection of Additional Data Followed the Study IFM 2013-04

Who this might be right for
Myeloma Multiple
Nantes University Hospital 340
Not applicableStudy completedNCT04408209
What this trial is testing

Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection

Who this might be right for
COVID-19 Infection
National and Kapodistrian University of Athens 60
Not applicableUnknownNCT02009787
What this trial is testing

Efficacy Study of Vitamin D and Statins to Treat Hypercholesterolemia

Who this might be right for
Primary Hypercholesterolemia
Shi Yang 56
Large-scale testing (Phase 3)Study completedNCT01499199
What this trial is testing

The Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 13
Not applicableNot Yet RecruitingNCT06450821
What this trial is testing

PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications

Who this might be right for
OncologyPeriodontitisMyeloma+2 more
University of Leeds 60
Not applicableEnrolling By InvitationNCT06730477
What this trial is testing

Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma

Who this might be right for
Lung AdenocarcinomaEGFR Activating Mutation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 500
Testing effectiveness (Phase 2)Ended earlyNCT01555281
What this trial is testing

Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma

Who this might be right for
Multiple Myeloma
Swiss Cancer Institute 33
Not applicableLooking for participantsNCT06698887
What this trial is testing

Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 15
Not applicableActive Not RecruitingNCT05889221
What this trial is testing

Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma

Who this might be right for
Multiple MyelomaMyeloma MultipleMyeloma
Poitiers University Hospital 74
Not applicableStudy completedNCT00513175
What this trial is testing

Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+8 more
University of California, San Francisco 44
Not applicableStudy completedNCT02140736
What this trial is testing

Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology

Who this might be right for
Chemotherapy-induced Symptomatic AnemiaSolid TumorsMalignant Hemopathies+2 more
Hospira, now a wholly owned subsidiary of Pfizer 2,333
Not applicableStudy completedNCT00049465
What this trial is testing

Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00089011
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more
Fred Hutchinson Cancer Center 150
Not applicableStudy completedNCT04797377
What this trial is testing

Autologous Intraovarian Platelet Rich Plasma Treatment in Women With Poor Ovarian Response

Who this might be right for
Poor Ovarian Reserve
Nadezhda Women's Health Hospital 66
Early research (Phase 1)Active Not RecruitingNCT05981209
What this trial is testing

Elotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory Myeloma After CD38- and BCMA-Targeted Therapies

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Abdullah Khan 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439175
What this trial is testing

Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 70
Early research (Phase 1)Ended earlyNCT04405167
What this trial is testing

Tasquinimod for the Treatment of Relapsed or Refractory Myeloma

Who this might be right for
Multiple Myeloma
University of Pennsylvania 30
Testing effectiveness (Phase 2)Ended earlyNCT05090566
What this trial is testing

MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pfizer 46
Next Page